# rs56007086 and Breast cancer (16q12)

Configuration `single`, named mode, seed 0. Models: generator openai/gpt-6-luna, critic openai/gpt-6-luna, summariser openai/gpt-6-luna. Cost $0.00 over 1 model calls; 48 s.

Variant `chr16:52565398:G>A` (germline); expression context: DepMap:ACH-000019 (MCF7).

## Ranked chains

### 1. H0: No TF-mediated effect of this variant (p = 0.60)

Null chain: no TF-mediated effect of this variant.

Predictions: The variant shows no reproducible allele-specific TF occupancy or regulatory activity.; Any disease association is due to linkage with another causal variant, another non-TF-mediated mechanism, or chance.

Falsified if: The variant reproducibly changes binding of an occupied TF and perturbing the variant changes a relevant gene's expression in an appropriate cell context.

### 2. H1: Alt allele increases FOXA1-mediated TOX3 regulation (p = 0.20)

TF FOXA1 (QBiC-SELEX coverage own_model), alt allele binds more; element The variant lies in or affects a cis-regulatory element at the 16q12 locus.; gene TOX3; cell type Luminal breast cancer cells, including MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | FOXA1 is a plausible luminal-lineage TF at this locus; this hypothesis predicts stronger binding to alt A. No variant-specific occupancy or QBiC-SELEX result is supplied, so the direction is unverified. | missing | none |
| element | The variant changes FOXA1 binding at a local cis-regulatory element. | missing | none |
| gene | The element regulates TOX3 in cis; increased FOXA1 binding is hypothesized to increase TOX3 expression. | missing | none |
| cell_type | The regulatory effect occurs in luminal breast cells such as MCF7. | missing | none |
| phenotype | The resulting change in TOX3 regulation contributes to breast cancer susceptibility. | missing | none |

Predictions: At the variant, FOXA1 occupancy is greater on alt A than ref G in an informative MCF7 assay.; The alt allele increases local enhancer activity and TOX3 expression in a luminal breast-cell context.

Falsified if: A well-powered allele-specific FOXA1 assay shows no occupancy difference or greater occupancy on ref G.; Perturbing the element has no effect on TOX3 expression in relevant breast cells.

### 3. H2: Ref allele supports GATA3-mediated TOX3 regulation (p = 0.12)

TF GATA3 (QBiC-SELEX coverage own_model), ref allele binds more; element The variant lies in or affects a cis-regulatory element at the 16q12 locus.; gene TOX3; cell type Luminal breast cancer cells, including MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | GATA3 is a plausible luminal-lineage TF; this alternative predicts stronger binding to ref G. No variant-specific occupancy or QBiC-SELEX result is supplied, so the direction is unverified. | missing | none |
| element | The variant changes GATA3 binding at a local cis-regulatory element. | missing | none |
| gene | The element regulates TOX3 in cis; this hypothesis predicts that GATA3 binding promotes TOX3 expression, making the alt allele relatively less active. | missing | none |
| cell_type | The effect occurs in luminal breast cells such as MCF7. | missing | none |
| phenotype | Reduced TOX3 regulation on the alt allele contributes to breast cancer susceptibility. | missing | none |

Predictions: At the variant, GATA3 occupancy is greater on ref G than alt A.; The ref allele supports greater local enhancer activity and TOX3 expression in a luminal breast-cell context.

Falsified if: A well-powered allele-specific GATA3 assay shows no occupancy difference or greater occupancy on alt A.; Perturbing the element has no effect on TOX3 expression in relevant breast cells.

### 4. H3: Alt allele changes ESR1-mediated regulation of a nearby gene (p = 0.08)

TF ESR1 (QBiC-SELEX coverage own_model), alt allele binds more; element The variant lies in or affects a cis-regulatory element at the 16q12 locus.; gene TOX3; cell type Estrogen-responsive luminal breast cancer cells, including MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | ESR1 is a plausible TF in estrogen-responsive MCF7 cells; this hypothesis predicts stronger binding to alt A. No variant-specific occupancy or QBiC-SELEX result is supplied, so the direction is unverified. | missing | none |
| element | The variant changes ESR1 binding at a local cis-regulatory element. | missing | none |
| gene | The element regulates TOX3 in cis; increased ESR1 binding is hypothesized to alter, but is not assumed to increase, TOX3 transcription. | missing | none |
| cell_type | The effect depends on estrogen-responsive luminal breast cells such as MCF7. | missing | none |
| phenotype | The ESR1-dependent regulatory change contributes to breast cancer susceptibility. | missing | none |

Predictions: ESR1 occupancy at the variant is greater on alt A and depends on estrogen signaling.; The allelic expression effect on TOX3 is stronger under estrogen-responsive conditions than without estrogen signaling.

Falsified if: ESR1 does not occupy the region in relevant cells or shows no allelic occupancy difference.; The allelic regulatory effect persists unchanged when estrogen signaling is removed.

## Prediction matrix

| Test | Cost | Separates top two | H0 | H1 | H2 | H3 |
| --- | --- | --- | --- | --- | --- | --- |
| Allele-specific FOXA1 and GATA3 binding assay in MCF7, using matched ref and alt sequence probes with TF-specific supershift or equivalent identification. | low | yes | No reproducible allele-specific binding supports the null, though the assay cannot exclude binding in chromatin. | Greater FOXA1 binding to alt A than ref G supports H1. | Greater GATA3 binding to ref G than alt A supports H2. | Neither predicted FOXA1 nor GATA3 pattern; this test does not directly test ESR1. |
| Allele-specific ESR1 occupancy in MCF7 with and without estrogen signaling. | medium | no | No allele-specific ESR1 occupancy is consistent with the null. | No specific estrogen-dependent ESR1 allelic occupancy is predicted. | No specific estrogen-dependent ESR1 allelic occupancy is predicted. | Greater ESR1 occupancy on alt A, modulated by estrogen signaling, supports H3. |
| CRISPR base editing of the variant in MCF7 followed by measurement of TOX3 expression. | high | yes | No reproducible expression effect supports the null. | Changing ref G to alt A increases TOX3 expression, as predicted by H1. | Changing ref G to alt A decreases TOX3 expression, as predicted by H2. | An alt-associated expression effect that depends on estrogen signaling supports H3. |

## Next experiment

Run a low-cost allele-specific FOXA1/GATA3 binding assay using matched ref and alt probes and TF-specific identification. It directly distinguishes the two highest-probability non-null chains, but a positive result would still need confirmation of occupancy and regulatory function in chromatin.

## Flags

- none

## Evidence
